These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7286031)

  • 1. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).
    Gulaid AA; James IM; Kaye CM; Lewellen OR; Roberts E; Sankey M; Smith J; Templeton R; Thomas RJ
    Biopharm Drug Dispos; 1981; 2(2):103-14. PubMed ID: 7248475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
    Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
    Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
    Zaman R; Jack DB; Wilkins MR; Kendall MJ
    Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
    Sankey MG; Gulaid A; Kaye CM
    J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
    Ohashi K; Warrington SJ; Kaye CM; Houghton GW; Dennis M; Templeton R; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):561-5. PubMed ID: 7295489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.
    Roux A; Le Liboux A; Delhotal B; Gaillot J; Flouvat B
    Eur J Clin Pharmacol; 1983; 24(6):801-6. PubMed ID: 6884417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS; Burm JP
    Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acebutolol pharmacokinetics in renal failure.
    Smith RS; Warren DJ; Renwick AG; George CF
    Br J Clin Pharmacol; 1983 Sep; 16(3):253-8. PubMed ID: 6626416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol.
    Zaman R; Wilkins MR; Kendall MJ; Jack DB
    Biopharm Drug Dispos; 1984; 5(1):91-5. PubMed ID: 6704510
    [No Abstract]   [Full Text] [Related]  

  • 12. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
    Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
    J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the pharmacokinetics of acebutolol.
    Kaye CM; Kumana CR; Leighton M; Hamer J; Turner P
    Clin Pharmacol Ther; 1976 Apr; 19(4):416-20. PubMed ID: 1269192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
    Mostafavi SA; Foster RT
    Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acebutolol disposition after intravenous administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):557-67. PubMed ID: 913023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].
    Kukes VG; Gneushev ET; Mamedov TSh; Gneusheva IA
    Farmakol Toksikol; 1991; 54(1):53-5. PubMed ID: 1860501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To nurse when receiving acebutolol: is it dangerous for the neonate?
    Boutroy MJ; Bianchetti G; Dubruc C; Vert P; Morselli PL
    Eur J Clin Pharmacol; 1986; 30(6):737-9. PubMed ID: 3770068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of grapefruit juice on the pharmacokinetics of acebutolol.
    Lilja JJ; Raaska K; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):659-63. PubMed ID: 16305592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.
    Zaman R; Jack DB; Kendall MJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):427-9. PubMed ID: 7295474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.